Literature DB >> 35820415

Distinct p53 isoforms code for opposing transcriptional outcomes.

Annika Wylie1, Amanda E Jones1, Simanti Das1, Wan-Jin Lu2, John M Abrams3.   

Abstract

p53 genes are conserved transcriptional activators that respond to stress. These proteins can also downregulate genes, but the mechanisms are not understood and are generally assumed to be indirect. Here, we investigate synthetic and native cis-regulatory elements in Drosophila to examine opposing features of p53-mediated transcriptional control in vivo. We show that transcriptional repression by p53 operates continuously through canonical DNA binding sites that confer p53-dependent transactivation at earlier developmental stages. p53 transrepression is correlated with local H3K9me3 chromatin marks and occurs without the need for stress or Chk2. In sufficiency tests, two p53 isoforms qualify as transrepressors and a third qualifies as a transcriptional activator. Targeted isoform-specific knockouts dissociate these opposing transcriptional activities, highlighting features that are dispensable for transactivation but critical for repression and for proper germ cell formation. Together, these results demonstrate that certain p53 isoforms function as constitutive tissue-specific repressors, raising important implications for tumor suppression by the human counterpart.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chk2; DNA binding motif; Drosophila; biosensor; chromatin modifications; corolla; p53; p53 isoforms; transactivation; transrepression

Mesh:

Substances:

Year:  2022        PMID: 35820415      PMCID: PMC9378576          DOI: 10.1016/j.devcel.2022.06.015

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   13.417


  64 in total

1.  Drosophila p53 binds a damage response element at the reaper locus.

Authors:  M H Brodsky; W Nordstrom; G Tsang; E Kwan; G M Rubin; J M Abrams
Journal:  Cell       Date:  2000-03-31       Impact factor: 41.582

2.  p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and Noxa.

Authors:  Liz J Valente; Daniel H D Gray; Ewa M Michalak; Josefina Pinon-Hofbauer; Alex Egle; Clare L Scott; Ana Janic; Andreas Strasser
Journal:  Cell Rep       Date:  2013-05-09       Impact factor: 9.423

Review 3.  Deconstructing networks of p53-mediated tumor suppression in vivo.

Authors:  Alyssa M Kaiser; Laura D Attardi
Journal:  Cell Death Differ       Date:  2017-11-03       Impact factor: 15.828

4.  The histone acetyltransferase PCAF regulates p21 transcription through stress-induced acetylation of histone H3.

Authors:  Ian M Love; Pedja Sekaric; Dingding Shi; Steven R Grossman; Elliot J Androphy
Journal:  Cell Cycle       Date:  2012-07-01       Impact factor: 4.534

Review 5.  Long noncoding RNAs in the p53 network.

Authors:  Ritu Chaudhary; Ashish Lal
Journal:  Wiley Interdiscip Rev RNA       Date:  2016-12-19       Impact factor: 9.957

6.  p53 directs focused genomic responses in Drosophila.

Authors:  F Akdemir; A Christich; N Sogame; J Chapo; J M Abrams
Journal:  Oncogene       Date:  2007-02-19       Impact factor: 9.867

Review 7.  Cause and consequence of cancer/testis antigen activation in cancer.

Authors:  Angelique W Whitehurst
Journal:  Annu Rev Pharmacol Toxicol       Date:  2013-10-11       Impact factor: 13.820

8.  Quality control and preprocessing of metagenomic datasets.

Authors:  Robert Schmieder; Robert Edwards
Journal:  Bioinformatics       Date:  2011-01-28       Impact factor: 6.937

9.  p53 activity is selectively licensed in the Drosophila stem cell compartment.

Authors:  Annika Wylie; Wan-Jin Lu; Alejandro D'Brot; Michael Buszczak; John M Abrams
Journal:  Elife       Date:  2014-03-11       Impact factor: 8.140

10.  p53 genes function to restrain mobile elements.

Authors:  Annika Wylie; Amanda E Jones; Alejandro D'Brot; Wan-Jin Lu; Paula Kurtz; John V Moran; Dinesh Rakheja; Kenneth S Chen; Robert E Hammer; Sarah A Comerford; James F Amatruda; John M Abrams
Journal:  Genes Dev       Date:  2015-12-23       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.